1.42% 0.0396

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga

60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada

60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World

60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com

SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan

60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - StockTitan

60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN

60 Degrees Pharmaceuticals announces private placement sale - Investing.com India

60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks

60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada

60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Australia

60 Degrees Pharmaceuticals announces private placement sale - Investing.com

60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com UK

60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - StockTitan

60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex

TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga

60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire

60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - StockTitan

60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements - TipRanks

60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors Australia

60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors Australia

60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors UK

60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors UK

60 Degrees Pharmaceuticals Inc’s Mixed Bag: Down -39.50% in 6 Months, Down -7.00% in 30 Days - The InvestChronicle

Market Resilience: 60 Degrees Pharmaceuticals Inc (SXTP) Finishes Strong at 1.58, Up 1.28 - The Dwinnex

60 Degrees Pharmaceuticals Inc (SXTP)’s stock price range in the last year - US Post News

Q3 2024 EPS Estimates for 60 Degrees Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:SXTP) - Defense World

60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Stock Rating Reaffirmed by HC Wainwright - Defense World

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Issues Quarterly Earnings Results - Defense World

Financial Contrast: 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Antibe Therapeutics (OTCMKTS:ATBPF) - Defense World

60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Australia

60 Degrees Pharmaceuticals reports doubled Q2 revenue - Investing.com

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - citybiz

Thinking about buying stock in Nio Inc, 60 Degrees Pharmaceutica - GuruFocus.com

60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

60 Degrees Pharmaceuticals reports doubled Q2 revenue - Investing.com India

60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Canada

SXTP60 Degrees Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - ForexTV.com

60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com UK

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - GlobeNewswire

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - Yahoo Finance

60 Degrees Pharmaceuticals Inc (SXTP) is looking forward to a strong quarter - SETE News

Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now? - Insider Monkey

Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now? - Yahoo Finance

60 Degrees Pharmaceuticals Inc (SXTP) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 29% Today? - InvestorPlace

Upcoming Stock Splits This Week (August 12 to August 16) – Stay Invested - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines

Upcoming Stock Splits This Week (August 12 to August 16) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News

A stock that deserves closer examination: 60 Degrees Pharmaceuticals Inc (SXTP) - US Post News

Bitcoin Miner Marathon to Sell Notes to Buy Cryptocurrency - Head Topics

Ratio Revelations: 60 Degrees Pharmaceuticals Inc (SXTP)’s Financial Metrics in the Spotlight - The Dwinnex

60 Degrees Pharma Provides University of Kentucky with - GlobeNewswire

60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study - StockTitan

WallachBeth Capital Announce Closing Of 60 Degrees Pharmaceuticals IPO At $5.30 Per Unit - Quantisnow

WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering - Quantisnow

Does 60 Degrees Pharmaceuticals Inc (SXTP) offer a good opportunity for investors? - SETE News

Analyzing the Impact of Earnings Reports on 60 Degrees Pharmaceuticals Inc Inc. (SXTP) Price Performance - The InvestChronicle

ARRY’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Agape ATP Corp Inc. (ATPC) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

60 Degrees Pharmaceuticals announces reverse stock split By Investing.com - Investing.com Canada

60 Degrees Pharmaceuticals Announces 1:12 Reverse Stock Split - citybiz

Ähnlich wie SXTP